Topic 2.2 Prokaryotic cells Flashcards
(27 cards)
Pilli
-Short hair-like structures on the cell surface
-They have a role in movement
-Are more often involved in adherence to surfaces, which facilitates infection and is a key virulence characteristic.
Flagella
-Primarily used for cell movement
-Spins creating forward movement
-Some prokaryote have more than one flagella, localised to one pole or spread out around the cell.
70S ribosomes
-These consist of a 30S subunit and a 50S subunit
-The smaller subunit is comprised of more than 20 proteins
-The larger subunit comprised of more than 30 proteins
-Their main role is in protein synthesis.
Nucleoid
-The space within prokaryotic cell where the genetic information (genophore) is found
-It doesn’t contain a membrane.
Plasmids
-Small loops of DNA that are separate from the main circular DNA molecule
-Plasmids contain genes that can be passed between prokaryotes.
Capsule
-A final outlier that surrounds some prokaryotes
-Sometimes called slime capsule
-Helps to protect bacteria from drying out.
Peptidoglycan
-Found in bacterial cell wall
-Made up of many parallel polysaccharide chains with cross links that form a net like structure.
How to distinguish between the two bacterial cell walls?
A technique called gram staining
Gram (+) cell wall
Have a thick peptidoglycan layer which means that stains get trapped in the cell wall leading to deeper colour when stained.
Gram (-) cell wall
Have a thin layer of peptidoglycan which means the stain doesn’t get trapped so much during the process and they have a lighter colour.
General viral structure
-Acellular: not living
-Has a protein coat or capsid
-Some have a lipid envelope which covers the protein coat which makes it easier for viruses to pass from cell to cell.
Virus shapes
-Helical
-Polyhedral
-Spherical
-Complex
Virus classification
-Mode of replication (lytic, lysogenic)
-Genetic material
-Capsule structure
-Host organism
-Size
Lambda phage (λ) virus
-Lambda phage is a virus particle consisting of a head containing 48514 base pairs of double stranded linear DNA
-It infect the bacterial species Escherichia coli (E coli)
-Usually goes through the lytic cycle and lambda DNA assembles in its host.
Tobacco mosaic virus
-Contains single stranded RNA as its genetic material
-It infects mostly tobacco plants and other membranes of the family Solanaceae
-Causes the mosaic/mottling discolouration on the leaves
Ebola virus
-Contains RNA which is the blueprint for assembling new virus
-A person infected with Ebola virus will typically develop a fever, headaches, joint and muscle pain, a sore throat and intense muscle weakness
-Symptoms start suddenly between 2 after becoming infected
-Ebola virus kills 90% of victims
-Breakout was in 2014
Human immunodeficiency virus (HIV)
-HIV contains two copies of single-stranded RNA which are transcribed into double-stranded DNA (by reverse transcription)
-It damages cells in the immune system and weakens your ability to fight everyday infections and diseases
-Most people experience a short flu-like illness 2 to 6 weeks after HIV infection, which last a week or two
-After the symptoms disappear, HIV may not cause any symptoms for many years later although the virus continues to damage the immune system.
Controlling disease
-Identifying contacts
-Rapid identification
-PPE
-Sterilising and disposing
-Avoiding contact
-Lockdowns
-Isolation
-Hygiene
-Social distancing
-Vaccines
-Vaccine passports
Developments of medicine
-Takes up to 10 years
-Costs millions of pounds
-Involves many scientists and doctors
Step 1 in developing medicines
(initial ideas)
Initial ideas come from:
-genome analysis
-computer modelling
-clinical compound banks
-medicinal plants
Step 2 in developing medicines
(research)
Go through research and testing on:
-cell and tissue cultures
-safety analysis
-molecular modifications
Step 3 in developing medicines
Animal testing is carried out to ensure it works in an organism and it is safe.
Step 4 in developing medicines
Three phases of human testing to further ensure safety and that the drug works (lots of complex regulation and licensing procedures).
Step 5 in developing medicines
Drug reaches the doctors surgery